| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4276940 | Urology Practice | 2016 | 8 Pages |
Abstract
Each marker represents an important advance in 1 or more disease settings. Further studies are needed to determine the comparative effectiveness and cost-effectiveness of these biomarkers, and identify which tests or combinations are most useful and usable.
Keywords
BCRPCA3CCPTMPRSS2PHIp2PSACAPRA-SDREFDAPSAProstate specific antigenProstate Cancer Antigen 3Sensitivity and specificityRiskRadical prostatectomyFood and Drug AdministrationGPSProstate health indexBiochemical recurrencedigital rectal examinationProstatic neoplasmsbiological markersActive surveillanceGenomic Prostate Scoreprostate-specific antigentransmembrane protease serine 2Cell cycle progression
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
John B. Eifler, William Sohn, Daniel A. Barocas,